Becton Dickinson (NYSE:BDX) and BioGX announced today that the FDA granted emergency use authorization (EUA) to their new diagnostic test for screening for COVID-19 on-site at hospitals. The new test is designed as an easy-to-use, rapid diagnostic test to screen for coronavirus and receive results in under three hours, according to a news release. The assay detects […]